Collects data on adults receiving stem cell transplants for blood cancers
Collects and stores data on adults undergoing stem cell transplant for blood cancers.
Plain-language title generated from the registry record
Registry title: The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Key facts
- Where
- Winston-Salem, United StatesSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are planned to have standard-care high-dose therapy followed by a bone marrow transplant, using their own cells or a donor's cells. Their data will be collected and stored.
- Age
- 18 to 120 years
- Sex
- All sexes can join.
- Earlier treatment
- The record says they must be planned for standard-of-care dose intensive therapy and either an allogeneic or autologous bone marrow transplant.
Main reasons for not taking part
- Taking part in any other treatment research protocol
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 120 years old?
Source: NCT01890486, who can take part
Where in United States
- Wake Forest Baptist HealthWinston-Salem, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Wake Forest University Health Sciences
- Trial code
- NCT01890486
- Record updated
- 13 April 2026
- Original description
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.Read full original descriptionShow less
The Prospective Collection, Storage and Reporting of Data on Patients
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Inclusion: Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant.
Exclusion: Participation in any other treatment research protocol.